Nxera Team


Our management team, board and scientific advisory board have vast experience in the global pharma industry and provide a wealth of expertise.

A portrait of Mr. Rolf Soderstrom

Mr. Rolf Soderstrom

External Independent Director

Rolf is currently Chief Financial Officer of Syncona Investment Management Ltd., a publicly traded life sciences investment firm, listed in the UK. He brings over 30 years’ experience in finance and a track record of accelerating the profitable growth of companies and delivering shareholder returns. He has extensive strategic, operational and international experience including M&A, fundraisings and disposals.

Most notably, Rolf was CFO of BTG plc from 2008 to 2018 where he helped drive the successful transformation of the company into a fully integrated global manufacturing and sales organisation focused on specialist healthcare. Before joining BTG, Rolf was Divisional Finance Director at Cobham Plc and Director of Corporate Finance at Cable & Wireless Plc. He qualified as a chartered accountant at PricewaterhouseCoopers where he worked initially in audit and then in the corporate finance function.

Rolf is currently a Non-executive Director of Ergomed plc and of BioPharma Credit plc.

He joined the Board of Directors of Nxera Pharma in March 2020.